skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Sunday, June 7, 2020

COVID-19 - How To Protect Yourself And Others - CDC.gov

The pandemic is not over yet!


The CDC tells us:

How to Protect Yourself & Others



Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 5:57 AM
Labels: cdc, COVID, guidelines, recommendations

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2026 #2027 #2028

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2026

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2026 #2027 #2028

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Food Poison Journal
    CDC: Infant Botulism hits Three in Washington, California and Pennsylvania
    4 hours ago
  • Medscape Today Headlines
    Off-Label Rxs: Thinking Out of the Box for Skin Diseases
    13 hours ago
  • eLearning Industry
    Explore The Future Of eLearning: Smart Ways Digital Education Is Transforming Learning
    13 hours ago
  • Wellness Blog - NY Times
    A New Option for Long-Term Care Costs
    23 hours ago
  • All Kaiser Health News
    Journalists Highlight Medical Neglect in ICE Detention, RFK Jr. Antidepressant Comments
    23 hours ago
  • JD Supra Law News
    60 Days and Counting: DOJ’s New Fast Track for Benefits Fraud Qui Tams
    1 day ago
  • FDA What's New: Drugs
    FDA Approves Drug for Pediatric Stage 3 Type I Diabetes
    1 day ago
  • FDA - Press Releases
    FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children
    1 day ago
  • Government Executive
    Anti-fraud overhaul clears House despite Democratic concerns over privacy and IG independence
    1 day ago
  • Marler Blog
    A Company’s Name Is Not a Trade Secret
    1 day ago
  • FierceBiotech
    Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’
    1 day ago
  • Pharmalot – STAT
    STAT+: Up and down the ladder: The latest comings and goings
    1 day ago
  • BioPharma Dive - Latest News
    Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
    1 day ago
  • BioPharma Dive
    Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
    1 day ago
  • Clarkston Consulting
    Retail Store Experience in 2026: What Makes Physical Stores Worth Visiting
    1 day ago
  • Drug Channels
    Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated Care (rerun)
    1 day ago
  • FierceBiotech: Medtech
    Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug
    1 day ago
  • Drug & Device Law
    We Were Wrong On 340B, Sort Of
    1 day ago
  • Science-Based Medicine
    MAHA Doctors Promised Kennedy Would be the Savior of Vaccines. What Happened Next?
    2 days ago
  • CNBC Health Care
    Healthy Returns: CVS Health executives on reducing healthcare's biggest pain points
    2 days ago
  • FiercePharma
    Novo reports data breach, tells clinical trial patients to 'remain vigilant'
    2 days ago
  • Pharmaceutical Commerce
    2 days ago
  • GEN Biotech News
    Potential Cocaine Addiction Targets Identified Through Genetic Mapping in Rats
    2 days ago
  • Quality Matters
    Managing mutagenic impurities: Stakeholders seek clarity, consistency, and practical tools for implementation
    2 days ago
  • Medtech Insight
    Execs On The Move: June 1–5, 2026
    2 days ago
  • Pharmafile
    Phase 2 study explores imaging approach for interstitial lung disease
    1 week ago
  • The Compliance and Ethics Blog
    New sheriff in town? Examining state enforcement of AI laws
    1 week ago
  • Clinical Correlations
    The History of Pacemakers and Where They Are Heading
    1 week ago
  • Asbestos and Mesothelioma News
    Fungus-Derived Compounds Show Promise Against Mesothelioma
    2 weeks ago
  • The Incidental Economist
    Why Long-Term Care Policy Keeps Failing – and How to Fix It
    3 weeks ago
  • Pharmafile - Mfg & Production
    Vetter begins construction of new injectable medicines facility
    3 weeks ago
  • World Pharma - Breaking News
    AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors
    5 weeks ago
  • FDA - Health Fraud
    Umary contains hidden drug ingredients
    2 months ago
  • Eye on FDA
    Is cooking with olive oil really beneficial for your health? Expert Answers
    2 months ago
  • Ted Eytan, MD
    San Juan, Puerto Rico
    3 months ago
  • NPR Blogs: Shots - Health News Blog
    Flu shot recommendation for kids dropped just as the illness rages
    5 months ago
  • Healthcare Packaging
    Practical Waste Recycling at the Hospital Level: What Are the Odds?
    6 months ago
  • 33 Charts
    The AI coding arms race
    7 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    11 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    1 year ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    1 year ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    1 year ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    1 year ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    1 year ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    1 year ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    1 year ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    2 years ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    2 years ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    2 years ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    2 years ago
  • Medgadget
    Plant-Based Soft Medical Robots
    2 years ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    3 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ▼  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ▼  June (2)
      • California Designated Representative Training Cour...
      • COVID-19 - How To Protect Yourself And Others - CD...
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo